698 A.2d 959 (Del. Ch. 1996)
In re Caremark International Inc. Derivative Litigation is the foundational Delaware case on directors' oversight duties—the so‑called "Caremark duties." Although the court was not adjudicating liability on the merits, Chancellor Allen used the occasion of a settlement approval to set out the standard for when directors can be held liable for failing to monitor the corporation's compliance and risk-control systems.
Under Delaware law, when can directors be held liable to the corporation for failing to monitor corporate compliance and risks—that is, for a breach of their oversight duties?
Directors have a duty to attempt in good faith to assure that a corporation has in place information and reporting systems reasonably designed to provide the board and senior management with timely, accurate information about the corporation's compliance and business performance. Oversight liability arises only in the rare case of a sustained or systematic failure of the board to exercise oversight—such as an utter failure to attempt to assure a reasonable information and reporting system exists—or a conscious failure to monitor or respond to red flags, evidencing a lack of good faith. While Caremark framed this in terms of evolving duty-of-care expectations, Delaware law (per Stone v. Ritter) later clarified that: - The oversight obligation is a component of the duty of loyalty via the requirement of good faith; and - Liability can arise under two prongs: (1) the board utterly failed to implement any reporting or information system or controls; or (2) having implemented such a system or controls, the board consciously failed to monitor or oversee operations, thereby disabling themselves from being informed of risks or problems, including by ignoring red flags.
The Court of Chancery approved the derivative settlement, concluding that plaintiffs' oversight liability claims faced a low likelihood of success. The court held that director liability for failure of oversight requires a sustained or systematic failure to exercise oversight—such as an utter failure to implement reasonable reporting systems—or a conscious disregard of red flags, a standard not supported by the record.
Caremark is the cornerstone of Delaware's oversight jurisprudence. It both (i) recognizes a board-level obligation to install and rely on reasonable information and reporting systems and (ii) sets a very high bar for imposing liability for failures of oversight. Stone v. Ritter later clarified that Caremark duties are part of the duty of loyalty (through good faith) and formalized the two-prong test (no systems at all, or conscious failure to monitor/ignore red flags). For students and practitioners, Caremark frames how to plead and defend oversight claims: plaintiffs must allege particularized facts supporting an inference of bad faith, not mere negligence or flawed business judgment. It also informs best practices for boards—standing compliance committees, regular board-level reporting on mission‑critical risk, documented responses to red flags—and has shaped subsequent cases (e.g., Marchand v. Barnhill, Boeing, and officer‑level oversight in McDonald's) concerning mission‑critical operations and the need for board‑level monitoring.